07/16/2022
In this clinical study, published in the journal Open Access Scientific Reports in 2012, researchers tested silver nanoparticles against three different human cancer cell lines, i.e., laryngeal cancer cells (Hep2), breast cancer cells (MCF 7) and colon cancer cells (HT29).